Rock Edwin's Form 4 filing
Crescent Biopharma, Inc. (CBIO) · filed Jun 24, 2024
- Accession no.
- 0001415889-24-017978
- Filed
- Jun 24, 2024, 4:29 PM ET
- Trade date
- Jun 20-21, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $78.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rock EdwinCIK 0001945417 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | Common Stock | PPurchaseAcquired | +190,000 | $0.2532 | +$48,108 | 565,403 | Direct | |
| Jun 21, 2024 | Common Stock | PPurchaseAcquired | +115,000 | $0.2671 | +$30,716.5 | 680,403 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.